AUSF - ETF AI Analysis

Top Page

Global X Adaptive U.S. Factor ETF (AUSF)

Rating:71Outperform

Price Target:―

The Global X Adaptive U.S. Factor ETF (AUSF) has a solid overall rating, driven by strong contributions from holdings like Royalty Pharma (RPRX) and TJX Companies (TJX). Royalty Pharma benefits from robust profitability, strategic acquisitions, and growth potential in the biotechnology sector, while TJX Companies showcases strong sales growth and improved profitability. However, the ETF's rating is slightly held back by weaker holdings such as Frontier Communications (FYBR), which faces significant challenges in profitability and cash flow. A key risk factor for this ETF is its exposure to stocks with varying financial stability, which could impact overall performance during market volatility.

Positive Factors

Strong Top Holdings

Several top holdings, such as Paramount Skydance and Electronic Arts, have delivered strong year-to-date performance, contributing positively to the ETF's returns.

Sector Diversification

The ETF is spread across 11 sectors, including Financials, Health Care, and Technology, reducing the risk of overexposure to any single industry.

Low Expense Ratio

With a competitive expense ratio of 0.27%, the fund offers cost-efficient access to its diversified portfolio.

Negative Factors

High Geographic Concentration

The ETF is heavily focused on U.S. companies, with over 99% exposure, limiting diversification across global markets.

Underperforming Holdings

Some holdings, such as Lockheed Martin and Verizon, have shown weak year-to-date performance, which could drag on overall returns.

Moderate AUM Size

The fund’s assets under management are relatively modest, which may limit liquidity compared to larger ETFs.

AUSF vs. SPDR S&P 500 ETF (SPY)

AUM762.70M

RegionNorth America

Expense Ratio0.27%

Beta0.60

IssuerGlobal X

Inception DateAug 24, 2018

Dividend Yield2.74%

Asset ClassEquity

Index TrackedAdaptive Wealth Strategies U.S. Factor Index (USD)

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume40,454

30 Day Avg. Volume52,925

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

51.84

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering193

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

AUSF Summary

The Global X Adaptive U.S. Factor ETF (AUSF) is an investment fund that focuses on the entire U.S. stock market, including large companies like AT&T and Walmart, as well as smaller firms. It uses a smart strategy to adjust its investments based on market trends, aiming to balance growth and risk. AUSF includes companies from various industries, such as technology, healthcare, and financials, making it a good option for investors seeking diversification across sectors. However, new investors should be aware that its performance can fluctuate with overall market conditions, so it’s important to consider your risk tolerance before investing.

How much will it cost me?The Global X Adaptive U.S. Factor ETF (AUSF) has an expense ratio of 0.27%, which means you’ll pay $2.70 per year for every $1,000 invested. This is slightly higher than average for ETFs because it uses an actively managed strategy to adapt to changing market conditions and optimize returns.

What would affect this ETF?The Global X Adaptive U.S. Factor ETF (AUSF) could benefit from positive trends in the U.S. economy, such as strong consumer spending and technological innovation, which align with its exposure to sectors like Consumer Defensive and Technology. However, rising interest rates or economic slowdowns may negatively impact sectors like Financials and Industrials, which are significant components of the fund. Additionally, regulatory changes or market volatility could influence the performance of top holdings like AT&T and Johnson & Johnson.

AUSF Top 10 Holdings

The Global X Adaptive U.S. Factor ETF (AUSF) leans heavily into financials, with Royalty Pharma providing steady growth thanks to its strong profitability and strategic acquisitions. Technology names like Cisco Systems are rising, buoyed by bullish momentum and a focus on AI, while consumer staples such as Walmart are also contributing positively with robust e-commerce growth. However, telecom giants Verizon and AT&T are lagging, weighed down by competitive pressures and high debt. With its U.S.-centric exposure and balanced sector mix, the fund offers a dynamic approach but faces headwinds from underperforming communication stocks.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
RPRX	Royalty Pharma	2.17%	$16.65M	$23.47B	57.98%	79 Outperform
VZ	Verizon	1.84%	$14.13M	$169.92B	3.06%	81 Outperform
DOX	Amdocs	1.76%	$13.50M	$8.84B	-1.83%	69 Neutral
T	AT&T	1.75%	$13.44M	$172.56B	8.07%	71 Outperform
TJX	TJX Companies	1.58%	$12.17M	$170.92B	26.62%	79 Outperform
LMT	Lockheed Martin	1.58%	$12.13M	$120.80B	5.98%	70 Outperform
RTX	RTX	1.58%	$12.11M	$255.28B	60.22%	74 Outperform
WMT	Walmart	1.57%	$12.07M	$911.31B	22.79%	78 Outperform
CSCO	Cisco Systems	1.57%	$12.05M	$297.24B	26.22%	77 Outperform
JNJ	Johnson & Johnson	1.56%	$12.01M	$493.40B	45.84%	78 Outperform

AUSF Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

45.78

Positive

100DMA

45.67

Positive

200DMA

44.28

Positive

Market Momentum

MACD

0.33

Negative

RSI

59.04

Neutral

STOCH

84.61

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AUSF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 46.66, equal to the 50-day MA of 45.78, and equal to the 200-day MA of 44.28, indicating a bullish trend. The MACD of 0.33 indicates Negative momentum. The RSI at 59.04 is Neutral, neither overbought nor oversold. The STOCH value of 84.61 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AUSF.

AUSF Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
AUSF	―	―	$762.70M	0.27%	―
SYLD	―	―	$865.98M	0.59%	―
PLDR	―	―	$841.85M	0.59%	―
ABFL	―	―	$772.60M	0.49%	―
PFM	―	―	$756.52M	0.52%	―
BGDV	―	―	$720.77M	0.45%	―

Performance Comparison

AUSF

Global X Adaptive U.S. Factor ETF

47.00

6.52

16.11%

SYLD

Cambria Shareholder Yield ETF

―

PLDR

Putnam Sustainable Leaders ETF

―

ABFL

Fcf Us Quality Etf

―

PFM

Invesco Dividend Achievers ETF

―

BGDV

Bahl & Gaynor Dividend ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents